XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Summary of Stock Option Activity

A summary of stock option activity under the 2020 Plan during the three months ended March 31, 2023 is as follows (in thousands except share and per share data):

 

 

 

Number of
Options
Outstanding

 

 

Weighted
Average
Strike
Price per
Option

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2022

 

 

6,757,289

 

 

$

27.60

 

 

 

8.01

 

 

$

55,934

 

Granted

 

 

1,930,540

 

 

 

31.25

 

 

 

 

 

 

 

Exercised

 

 

(208,705

)

 

 

7.12

 

 

 

 

 

 

 

Forfeited

 

 

(187,393

)

 

 

39.41

 

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

8,291,731

 

 

$

28.70

 

 

 

8.27

 

 

$

67,120

 

Exercisable at March 31, 2023

 

 

3,711,610

 

 

$

24.28

 

 

 

7.42

 

 

$

48,572

 

Summary of Equity-Based Compensation Expense

Total equity-based compensation expense recorded as research and development and general and administrative expenses for employees, directors, and non-employees during the three months ended March 31, 2023 and 2022 is as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

4,729

 

 

$

3,906

 

General and administrative

 

 

4,656

 

 

 

3,967

 

Total equity-based compensation

 

$

9,385

 

 

$

7,873

 

Summary of Weighted-Average Assumptions

The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant date fair value of stock options granted to employees and non-employees for the three months ended March 31, 2023 and 2022 were as follows:

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Expected term (in years)

 

 

5.82

 

 

 

5.81

 

Volatility

 

 

62

%

 

 

62

%

Risk-free interest rate

 

 

4.14

%

 

 

1.59

%

Dividend yield

 

 

0.00

%

 

 

0.00

%

Stock Options  
Summary of Equity-Based Compensation Expense

The following table outlines our equity-based compensation expense for stock options for the three months ended March 31, 2023 and 2022:

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Research and development

 

$

4,184

 

 

$

3,689

 

General and administrative

 

 

4,349

 

 

 

3,912

 

Total equity-based compensation

 

$

8,533

 

 

$

7,601

 

Summary of Restricted Stock Activity

The Company has granted shares of restricted common stock with service-based and performance-based vesting conditions. A summary of restricted stock activity during the three months ended March 31, 2023 is as follows:

 

 

 

Number of
Units
Outstanding

 

 

Grant Date
Fair Value
per Share

 

Unvested at December 31, 2022

 

 

281,843

 

 

$

23.64

 

Granted

 

 

216,289

 

 

 

30.84

 

Vested

 

 

(28,141

)

 

 

38.53

 

Forfeited

 

 

(17,270

)

 

 

25.84

 

Unvested at March 31, 2023

 

 

452,721

 

 

$

26.07